The major purpose of this study was to determine the effect of procyanidins extracted from the lotus seedpod (LSPC) on the nitric oxide (NO) system in the hippocampus and cerebral cortex in cognitively impaired aged rats. Using the Morris water maze, aged-unimpaired (AU) and aged-impaired (AI) rats were chosen from aged rats. All aged rats exhibited elevated inducible nitric oxide synthase (iNOS) activities and decreased neuronal nitric oxide synthase (nNOS) activities in the both brain regions. The changes were more pronounced in the brain of AI rats, especially in the hippocampus. Furthermore, AI rats greatly lowed the percentage of change of hippocampal nNOS activity in the presence of protein kinase inhibitors or phosphatase inhibitor, which meant that AI animals existed in a hardly modified nNOS dephosphorylated state in hippocampus. LSPC supplementation [50, 100 mg/kg of body weight (BW), per os (p.o.)] for 7 weeks significantly decreased iNOS activities and improved hippocampal nNOS phosphorylation status in AI animals. These results suggested that changes in the NO system may involve in the ameliorative effects of LSPC on cognitive deficits in AI animals.
Introduction

F
or most species, aging is an inevitable process involving a variety of progressive physiological and pathological changes. Declining cognitive functions, including the deterioration of learning and memory functions, is a common phenomenon in central nervous system (CNS) aging. A number of studies have demonstrated the marked declines in learning and memory abilities in the course of normal aging. [1] [2] [3] As a versatile diffusible messenger, nitric oxide (NO) has been reported in recent years to exert multiple actions in the normal physiological regulation of CNS. [4] [5] [6] Its implication in cognition has been well documented. 4, 5 For example, NO is associated with the regulation of learning and memory processes 5, 7 because it can act as a retrograde messenger to induct and maintain long-term potentiation (LTP) and longterm depression (LTD) through the NO/soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP) pathway and other mechanisms. [5] [6] [7] [8] In contrast, nitric oxide synthase (NOS) inhibitors impair learning and memory functions. 9, 10 Moreover, low concentrations of NO have been shown to exert cytoprotective effects via various mechanisms. 5, 6 However, the overproduction of NO could result in neurotoxicity, 6, [11] [12] [13] which is also related to cognitive deficits. NO is synthesized by three isoforms of NOS, which catalyzes the conversion of L-arginine to L-citrulline and NO. Of these NOS isoforms, the neuronal (nNOS or NOS I) and endothelial (eNOS or NOS III) are Ca 2þ -dependent, constitutive isoenzymes (cNOS), whereas the inducible isoform (iNOS or NOS II) is Ca 2þ -independent and only shows significant expression upon immunological or inflammatory stimulation.
Procyanidins are a class of polyphenolic compounds that are widely distributed in fruits, vegetables, seeds, flowers, bark, and wines. In recent years, these compounds have received increased attention in many fields, such as nutrition, medicine, and health due to their excellent antioxidant capacity and a broad spectrum of safety. Procyanidins possess significantly better free-radical scavenging capability than vitamin C, E, or b-carotene.
14 In addition, these compounds have a wide range of biological activities, including antibacterial, antiviral, antiinflammatory, and anticarcinogen actions. 15 In addition to the beneficial properties mentioned above, we and other researchers have found that procyanidins are able to ameliorate the learning and memory impairment in the cognitively impaired individuals, such as scopolamineinduced memory impairment mice, 16 senescence-accelerated mice, 17, 18 aged rats, 19 or elderly population. 20 The mechanisms involved were mainly the rejuvenations of antioxidant [17] [18] [19] and cholinergic 16, 19 systems as well as hippocampal cAMP response element-binding (CREB) protein phosphorylation. 21 For aged rodents, the age-related changes of the NO system in memory-related brain regions have been widely reported. [22] [23] [24] [25] [26] [27] [28] There is increasing evidence suggesting that procyanidins from various natural sources are able to modulate the activities of all three NOS isoforms 18, [29] [30] [31] and NO metabolism. 29 Therefore, it is certainly to be expected that the role of these compounds in learning and memory for the cognitively impaired aging individuals may be mediated, at least partly, through the modulation of the NO system in memory-related brain regions. In the present study, we use the procyanidins extracted from the lotus seedpod (LSPC), which has been reported to have ameliorative effects on cognitive deficits in aging rodents, 16, 18, 19 to assess the effects of these compounds on the NO system in hippocampus and cerebral cortex, two brain regions critical to learning and memory, of cognitively impaired aged rats.
Materials and methods
Materials
LSPC powder was obtained from the Natural Product Laboratory of Hua Zhong Agriculture University, China. Its extraction and isolation, 16, 32 chemical character (such as the composition and molecular weight), 32 as well as other characteristics have been reported in detail. 18, 32, 33 Animals Two hundred 13-month-old female Sprague-Dawley rats were obtained from Sino-British Sippr/BK (Shanghai, China). The rats were housed individually in plastic cages under the conventional facility and maintained at a controlled ambient temperature (24 AE 18C) under diurnal conditions (light-dark, 08:00-20:00) with access to laboratory chow and tap water ad libitum. The 40 young female controls were obtained at 3 months of age from the same supplier. At the time of the experiment, the young adult animals were 4 months of age, and the aged animals were 18 months of age. The health of the animals was monitored weekly by a veterinarian, and any animals with overt signs of chronic respiratory distress, infection, or tumors were removed from the study. The animals were cared for in accordance with the Guiding Principles in the Care and Use of Animals. The experiment was approved by the Tongji Medical College Council on Animal Care Committee, Huazhong University of Science and Technology, China.
Behavioral screening
Aged rats with memory impairment were screened by the Morris water maze test; the process has been described in detail in our previous work. 19 The cognitive status of an aged animal was determined on the basis of its escape latencies on days 3-5 of testing in the Morris water maze relative to the mean latency of young controls. An aged-impaired (AI) rat was defined as one whose mean latency (across days 3-5 of testing) differed by >3.0 standard deviations (SDs) from that of young controls. An aged animal was considered age unimpaired (AU) if its mean latency score was <0.5 SD from the mean of the young controls. Aged animals whose mean escape latencies fell between these values were not used in any further tests.
Study design
The rats in young control group (n ¼ 14) and AU group (n ¼ 16) were randomly selected from the young rats and AU rats, respectively. The animals categorized as AI were randomly subdivided into three groups consisting of 16 animals each: AI group, low-and high-dose LSPC (L-and H-LSPC) groups. Rats in L-and H-LSPC groups were given 50 and 100 mg/kg of body weight (BW) LSPC orally by a gavage daily for 7 weeks, respectively. The LSPC powder was dissolved in distilled water, and the LSPC solution was freshly prepared every day throughout the experimental period. The other three groups were given an equivalent volume of distilled water daily administered orally.
The learning and memory abilities of rats in different groups were assessed by retraining the animals in the Morris water maze with entirely different cues and then testing the animals as before. On each day of the behavioral tests period, animals continued to be administered LSPC or distilled water intragastrically 1 h before the first trial session. The behavioral performances in the Morris water maze trials for these animals was reported in full in our previous paper. 19 
Tissue preparation
After completion of water maze test, the number of rats in groups young, AU, AI, L-and H-LSPC was 14, 14, 13, 12, and 13, respectively. All animals were killed by decapitation under anesthesia. The brain was removed immediately and washed with ice-cold normal saline; then the hippocampus and cerebral cortex were dissected. Four animal samples in each group were randomly selected and frozen in liquid nitrogen and stored at À808C for real-time polymerase chain reaction (PCR) and western blot analysis. For the remaining animal samples, the hippocampus and cerebral cortex in the left hemisphere were weighed, and a 5% homogenate was prepared in a 50 mmol/L phosphate buffer (pH 7.0). Part of the homogenate was centrifuged at 3,500 rpm for 10 min at 48C, and the homogenate supernatant was collected for nitrite level and NOS activity evaluation. The remaining homogenate was prepared for another study 19 by adding ethylenediaminetetraacetic acid (EDTA).
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Assay of NO system
Assay of nitrite level. The presence of NO was assessed by measuring the amount of nitrite using commercial kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) based on Griess reactions. Briefly, after conversion of nitrate to nitrite with nitrate reductase, the addition of Griess reagents converted nitrite into a deep purple azo compound. The nitrite level was determined by measuring the absorbance at an optical density of 550 nm.
Assay of NOS activity. NOS activity was evaluated using commercial kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) based on Griess reactions. Briefly, the total NOS (tNOS) activity was assayed by adding the supernatant of homogenate to the incubation buffer containing bis-tris propane (pH 7.2), L-arginine, dithiothreitol (DTT), nicotinamide adenine dinucleotide phosphate (NADPH), tetrahydro-L-biopterin, and CaCl 2 . NADPH was removed with lactate dehydrogenase and sodium pyruvate at the end of reaction. Nitrite levels were determined using Griess reagents. The activity of iNOS was further characterized by incubation with EDTA instead of CaCl 2 . cNOS activity was calculated by subtracting iNOS from tNOS activity. One unit of activity was defined as the amount of enzyme producing 1 nmol of NO/min, and NOS activity was expressed as U/mg protein.
It should be pointed out that although the NOS activity assaying method employed in the current study does not distinguish between cNOS isoforms activities, nNOS is the predominant isoform in brain, accounting for most of the cNOS activity. 34 More than 98% of cNOS activity in the hippocampus appears to be nNOS activity. 35 Therefore, the cNOS activity was also regarded as nNOS activity in this study.
Determination of the effect of phosphorylation/dephosphorylation on nNOS activity. Various protein kinases, such as cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA), protein kinase C (PKC), and Ca 2þ / calmodulin-dependent protein kinase, can phosphorylate nNOS with different serine sites and thus decrease the catalytic activity of the enzyme. [36] [37] [38] On the other hand, protein phosphatases reverse nNOS phosphorylation and stimulate this enzyme activity. 39 In the present study, the effect of phosphorylation/dephosphorylation on nNOS activity was estimated by the method of Jesko et al. 40 Hippocampal and cortical homogenate were preincubated for 10 min at 308C in the presence of protein kinase inhibitors cocktail (10 mM H-7 and 10 mM H-8) or 50 mM phosphatase inhibitor sodium orthovanadate. The reaction was carried out for 20 min at 378C and terminated with ice-cold 100 mM HEPES, pH 5.5, with 10 mM ethylene glycol tetraacetic acid (EGTA). The next steps were performed as described for nNOS activity measurements.
Assay of protein concentration
The protein concentration was determined by the method of Lowry, 41 using bovine serum albumin (BSA) as a standard.
Reverse transcription by real-time PCR
Total RNA of the hippocampus and cerebral cortex in right hemisphere was isolated using TRIzol (Invitrogen) as directed by the manufacturer's instructions. Using the RT system (Takara Bio, Dalian, China), cDNA was synthesized from 2 mg at 378C for 15 min followed by 858C for 5 sec. Realtime PCR was performed with SYBR Ò Premix Ex Taq TM (Takara Bio, Dalian, China), using the ABI 7900HT real-time thermocycler (Applied Biosystems, Forster, CA), and the cycle conditions were 958C for 30 sec and 40 cycles of 958C for 5 sec and 608C for 30 sec. The dissociation curve of each gene was performed and analyzed using ABI 7900HT software, and the result confirmed the product specificity. Each sample was analyzed three times and normalized to b-actin.
The results of real-time PCR were analyzed with the 2
ÀDDCt method, as previously described. 42 The sequences of the primers for the genes in this study were as follows: nNOS, forward, 5
Western blot analysis
The hippocampus and cerebral cortex in the left hemisphere were homogenized with a glass homogenizer in icecold lysis buffer containing 50 mM Tris (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 1% sodium deoxycholate, 1% sodium dodecyl sulfate (SDS), 0.1 mM DTT, 0.05 mM phenylmethylsulfonyl fluoride (PMSF), 10 mM sodium fluoride (NaF), 0.5 mM sodium orthovanadate (Na 3 VO 4 ), and protease inhibitor cocktail (Amresco Inc, USA) and then left at 48C for 2 h. The supernatant was then collected as cytosolic fraction by centrifugation at 48C at 10,000Âg for 15 min and protein content was estimated by the Bio-Rad Dc protein assay reagent (Bio-Rad, Hercules, CA). Samples were mixed with SDS sample buffer and incubated for 5 min at 988C before loading. An equal amount of tissue proteins (30-50 mg/lane) was separated by 12-15% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and then proteins were transferred to polyvinylidene difluoride (PVDF) membranes by semidry electroblotting. The membranes were blocked with 5% bovine serum albumin (BSA) for 1 h at room temperature and incubated with a specific primary antibody overnight at 48C, followed by incubation with a species-appropriate horseradish peroxidase (HRP)-conjugated anti-rabbit antibody (1:3000)(Proteintech Group Inc.) for 1 h. After washing, the immunoreactive bands were detected by means of either SuperSignal West Pico or SuperSignal West Dura enhanced chemiluminescene solution (Pierce). The images were captured and analyzed using the GeneSnap and GeneTools software (Syngene), respectively, and all data were expressed as ratios to b-actin protein. The specific primary antibodies used were nNOS antibody (1:1,000 dilution) (#4234, Cell Signaling Technology); iNOS antibody (1:1,000 dilution) (sc-649, Santa Cruz Biotechnology), and b-actin antibody (1:1,000 dilution) (#3700, Cell Signaling Technology).
Statistical analysis
Values are presented as mean AE standard error of the mean (SEM). The measurement data were analyzed by oneway analysis of variance (ANOVA), followed by the Fisher protected least significant difference (PLSD) post hoc test if the overall differences were significant ( p < 0.05). All statistical analyses were performed using SPSS 13.0 statistical software (SPSS Inc., Chicago, IL), and a difference was considered significant when p < 0.05.
Results
Effect of LSPC on the NO level
As shown in Fig. 1 , there was no significant change in hippocampal NO levels between young and AU animals. However, the hippocampal NO levels in AI animals were markedly higher than that in young and AU animals. In the cerebral cortex, the NO levels were significantly increased in both AU and AI animals when compared with their young counterparts, and no difference was observed between AU and AI rats. Animals in both LSPC supplementation groups showed significantly lower hippocampal and cortical NO levels than AI and AU rats. Although there were comparable hippocampal NO levels between young and L-LSPC groups or between L-LSPC and H-LSPC groups, the H-LSPC group revealed significantly decreased hippocampal NO levels compared with young group. In addition, no significant changes were detected in cortical NO levels between young and L-LSPC groups or between young and H-LSPC groups, but the cortical NO levels in the H-LSPC group were notably more reduced than in the L-LSPC group.
Effect of LSPC on the NOS activities
The alterations in tNOS activity of both brain regions closely paralleled the changes in NO level of that in all the experimental groups. As shown in Fig. 2a , no difference in hippocampal tNOS activity was observed between young and AU groups. However, the AI group had significantly higher hippocampal tNOS activity than the young and AU groups. There were substantial increases in cortical tNOS activities for the AU and AI groups when compared with the young group, and no difference in activity was observed between the AU and AI groups. Animals in both LSPC supplementation groups revealed markedly lower cortical tNOS activities than AI and AU animals. Furthermore, the cortical tNOS activities in L-LSPC supplementation animals were comparable to young subjects, and the H-LSPC group had a significantly lower cortical tNOS activity than the young group. However, animals in both LSPC supplementation groups showed significantly lower hippocampal tNOS activities than not only AI and AU animals but also their young counterparts.
In Fig. 2b , young animals had minimal hippocampal and cortical iNOS activities among all the experimental groups. Although AU animals had a tendency to increase hippocampal iNOS activities, no significant difference was observed between young and AU animals, whereas iNOS activities for AI animals were significantly higher than young and AU animals. AU and AI animals showed significantly higher cortical iNOS activities than their young counterparts, and no significant difference between the two aged animal groups was detected. Supplementation of LSPC resulted in significant decreases in hippocampal and cortical iNOS activities when compared with the AI group. Although animals in both LSPC supplementation groups still exhibited significantly higher hippocampal iNOS activities than young animals, the levels of hippocampal iNOS activities in both LSPC groups were comparable to those in the AU group. Animals with LSPC supplementation revealed significantly lower cortical iNOS activities than their aged partners. Furthermore, animals with H-LSPC supplementation had similar comparable cortical iNOS activities with young rats.
As shown in Fig. 2c , hippocampal and cortical nNOS activities were significantly decreased in all aged animals when compared with those in young animals, and there were no significant alterations in cortical nNOS activity in all aged groups. In contrast, hippocampal nNOS activities were observed to be significantly lower in AI and both LSPC supplementation animals relative to AU rats, and there were no significant differences in hippocampal nNOS activity among AI and both LSPC supplementation groups.
Effect of LSPC on the mRNA level for particular NOS isoforms
As shown in Fig. 3a , AU animals showed significantly higher hippocampal and cortical iNOS mRNA expression than young subjects, and AI animals revealed further significant increase in hippocampal and cortical iNOS mRNA expression relative to AU rats. However, aged animals with LSPC supplementation uniformly exhibited significantly lower iNOS mRNA expression in both brain regions than AI animals. Furthermore, the hippocampal iNOS mRNA level of the H-LSPC supplementation group was significantly reduced compared to that of the L-LSPC group and reached to the level of young group.
As shown in Fig. 3b , hippocampal and cortical nNOS mRNA levels were significantly decreased in aged animals
FIG. 1. Effect of lotus seedpod (LSPC)
[50 and 100 mg/kg of body weight (BW)] on the nitrite level in the hippocampus and cerebral cortex of aged-impaired (AI) rats. Young, the young group; AU, aged-unimpaired group; AI, agedimpaired group; L-and H-LSPC, L-and H-LSPC groups. The number of rats in groups young, AU, AI, L-, and H-LSPC was 10, 10, 9, 8, and 9, respectively. Bars represent the mean AE standard error of the mean (SEM). Groups sharing different letters above the bars have statistically significant differences (P < 0.05), whereas those denoted by any same letters are insignificant.
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compared to those in their younger counterparts. Hippocampal nNOS mRNA levels were further markedly reduced in AI animals relative to AU animals, whereas the cortical levels did not significantly differ between the two groups. LSPC supplementation had a tendency to increase hippocampal nNOS mRNA levels, and the hippocampal nNOS
FIG. 3. Effects of lotus seedpod (LSPC)
[50 and 100 mg/kg of body weight (BW)] on the mRNA level of inducible nitric oxide synthase (iNOS) (a) and neuronal nitric oxide synthase (nNOS) (b) in the hippocampus and cerebral cortex of AI rats. Young, the young group; AU, aged-unimpaired group; AI, aged-impaired group; L-and H-LSPC, L-and H-LSPC groups. Bars represent the mean AE standard error of the mean (SEM) from four independent experiments. Groups sharing different letters above the bars have statistically significant differences ( p < 0.05), whereas those denoted by any same letters are insignificant.
FIG. 2.
Effect of lotus seedpod (LSPC [50 and100 mg/kg of body weight (BW)] on the activities total nitric oxide synthase (tNOS) (a), inducible nitric oxide synthase (iNOS) (b), and neuronal nitric oxide synthase (nNOS) (c) in the hippocampus and cerebral cortex of aging-induced (AI) rats. Young, the young group; AU, aged-unimpaired group; AI, aged-impaired group; L-and H-LSPC, L-and H-LSPC groups. The number of rats in groups young, AU, AI, L-and H-LSPC was 10, 10, 9, 8, and 9, respectively. Bars represent the mean AE standard error of the mean (SEM). Groups sharing different letters above the bars have statistically significant differences ( p < 0.05), whereas those denoted by any same letters are insignificant.
‰ LSPC IMPROVE THE NO SYSTEM IN AI RATS
mRNA level in H-LSPC supplementation group was significantly higher than AI group and comparable with the AU group. In contrast, cortical nNOS mRNA levels were found not to be significantly altered in response to LSPC supplementation.
Effect of LSPC on the protein content for particular NOS isoforms
As shown in Fig. 4a , young animals showed minimal iNOS protein contents in both brain regions. Hippocampal and cortical iNOS protein contents for AU animals were significantly higher than their young counterparts, and AI animals exhibited further significantly increased hippocampal and cortical iNOS protein contents when compared with AU rats. Animals in both LSPC supplementation groups showed the marked decline in hippocampal and cortical iNOS protein contents relative to AI animals. No significant differences in hippocampal and cortical iNOS protein contents were observed between AU and L-LSPC supplementation animals, and animals in the H-LSPC supplementation group showed no significant difference in hippocampal and cortical iNOS protein contents when compared with young animals.
As shown in Fig. 4b , hippocampal and cortical nNOS protein contents in all aged rats were noticeably lower than that in young animals. The differences in cortical nNOS protein contents among the four aged groups were not statistically significant. However, AI rats showed markedly lower hippocampal nNOS protein contents than the AU animals. LSPC supplementation tended to increase the hippocampal nNOS protein content and the hippocampal nNOS protein contents in both LSPC supplementation groups were comparable to AU group.
Effect of LSPC on the nNOS activity and the percentage of nNOS activity change with phosphorylation/dephosphorylation alteration As shown in Fig. 5a , in the presence of protein kinase inhibitors, hippocampal and cortical nNOS activities in all aged groups were evidently lower than that in young group, and the differences in cortical nNOS activity in all aged groups remained unsubstantial, whereas hippocampal nNOS activity of the AU group was significantly higher than that of other aged groups. In Fig. 5b , in the presence of phosphatase inhibitor, the young group exhibited significantly higher cortical nNOS activity than all aged groups, and no significant differences were observed in that activity in all aged groups. The young group also possessed significantly higher hippocampal nNOS activity than all aged groups except the AI group. Moreover, hippocampal nNOS activity of AU group was comparable with that of other aged groups. Moreover, when compared with the natural activity of nNOS in each group (Fig. 2c) , hippocampal and cortical nNOS activities in all groups changed in different extents in the presence of these inhibitors (increasing with protein kinase inhibitors and decreasing with phosphatase inhibitor).
The percentage of change in nNOS activity indicated the change of phosphorylation state in the presence of protein kinase inhibitors (Fig. 5c ) and the change of dephosphorylation state in the presence of phosphatase inhibitor (Fig. 5d) . As shown in Fig. 5, c and d, the percentages of hippocampal   FIG. 4 . Effects of lotus seedpod (LSPC) [50 and100 mg/kg of body weight (BW)] on the protein content of inducible nitric oxide synthase (iNOS) (a) and neuronal nitric oxide synthase (nNOS) (b) in the hippocampus and cerebral cortex of aging-induced (AI) rats. Representative immunoblot comparing relative levels of iNOS and nNOS protein in the hippocampus and cerebral cortex are shown above graphs. Young, the young group; AU, aged-unimpaired group; AI, aged-impaired group; L-and H-LSPC, L-and H-LSPC groups. Bars represent the mean AE standard error of the mean (SEM) from four independent experiments. Groups sharing different letters above the bars have statistically significant differences ( p < 0.05), whereas those denoted by any same letters are insignificant.
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and cortical nNOS activity change in the young group were significantly higher than all aged groups in the presence of these inhibitors, and the AU group exhibited a comparable percentage of cortical nNOS activity change with other aged groups. However, the AU group showed a notably higher percentage of hippocampal nNOS activity change than the other three aged groups, and there were no differences in those observed among AI and both LSPC groups in the presence of protein kinase inhibitors (Fig. 5c) . As for the percentage of hippocampal nNOS activity change in the presence of phosphatase inhibitor, the AI group showed a greatly significant decrease when compared with the AU group. However, LSPC supplementation resulted in a dosedependent, significant increase for the percentage of hippocampal nNOS activity change, and furthermore, the H-LSPC supplementation group reached the level of AU group for that activity in the presence of phosphatase inhibitor.
Discussion
Increasing evidence has demonstrated that NO plays a prominent role in the process of learning and memory. In addition to other various mechanisms associated with learning and memory, [5] [6] [7] [8] NO serves as a retrograde messenger in the glutamate/NOS/NO/sGC/cGMP pathway, which is a milestone discovery in this field of research. Through this pathway, NO triggers key events in synaptic plasticity involved in learning and memory, such as LTP. initiates an intracellular second-messenger cascade and then initiates LTP. Ca 2þ influx also leads to the activation of Ca 2þ /calmodulin, which activates nNOS and causes the release of NO from postsynaptic neurons. NO diffuses and acts on its target. The most prominent natural target of NO is sGC, whose activation produces cGMP and in turn activates other second-messenger systems. 7 Normal nNOS activity accounts for the majority of the physiological actions of NO in the process of learning and memory, although eNOS has also been reported to be involved. 35 However, the overproduction of NO from either nNOS or iNOS may lead to neurotoxicity through several mechanisms. 6, [11] [12] [13] Most importantly, due to its free radical properties, NO can generate reactive nitrogen species (RNS), which can induce significant oxidative stress.
In accord with other studies, 26 our results indicated that NO production in the young brain is mediated primarily by nNOS with minimal iNOS activity as well as gene and protein expression. These results indicated the absence of an infectious or immunogenic process in young brain. Aging affects NOS isoforms differently in different brain regions, but the previous literature has documented markedly different NOS isoform change patterns across the CNS. [23] [24] [25] [26] [27] 40, [43] [44] [45] The discrepancy may come from the differences of rat strains, diet, conditions of their breeding, health conditions, and so on. For example, iNOS expression is absent in brain for specific pathogen-free (SPF) aged rats maintained behind isolation barriers. 40 In the present study, the NO level and tNOS activity increases in the aged brain were primarily due to significant iNOS activity enhancement. AI rats exhibited significantly higher hippocampal iNOS activities than AU and young animals, and no differences in hippocampal iNOS activity were observed between young and AU animals. In addition, although a marked decrease in hippocampal nNOS activity occurred in all AU and AI rats, AI animals exhibited further significant lower hippocampal nNOS activities than AU animals. However, although cortical iNOS activities were increased by a large margin and at the same time nNOS activities were reduced in all AU and AI animals, there were no differences in both iNOS and nNOS activities between AI and AU animals.
Similar alteration trends were also observed in terms of the gene and protein expression in both iNOS and nNOS. These results suggested that alterations of expression and activity in hippocampal, but not cortical, iNOS and nNOS accounted for the reduced cognitive behaviors in AI animals. Furthermore, although in both parts of the aged brain nNOS activity was lower than in young animals, hippocampal nNOS gene and protein expression decreased at a greater degree, and this especially happened in AI animals. As a result, it was concluded that the AI animals had a great increase in nNOS activity per unit protein in hippocampus. This phenomenon was most likely caused by a change in nNOS phosphorylation, because aged brain exhibits lower PKA and PKC activity but activated phosphatases, 44, [46] [47] [48] [49] which alters the balance between protein kinase and phosphatase activities and then decreases the phosphorylation state of nNOS.
Consistent with this work, when treated with protein kinase inhibitors or phosphatase inhibitor, although the young group revealed the most alteration in the percentage of nNOS activity change, the AU group also had considerable changes in that activity. However, the effects of these inhibitors on the percentages of nNOS activity change were almost abrogated in the hippocampus of AI animals, which meant that the hippocampus of AI animals exists in a nNOS dephosphorylated state and the enzyme cannot be further modified, even in the presence of these inhibitors. 40 The sustained induction of NO synthesis by nNOS dephosphorylation during aging does not imply the enhancement of LTP. In contrast, because the whole pool of nNOS in hippocampus of AI animals exists in a dephosphorylated state that is hardly modified 40 and concomitantly decreases nNOS sensitivity to Ca 2þ /calmodulin in brain of AI animals, aging significantly reduced NMDA receptor-dependent NO synthesis, 22 which may subsequently decrease the NO/sGC/ cGMP signal transduction in the brains of AI animals. In addition, besides exerting its neurotoxicity and thereby deteriorating the physiological functions of brain, NO overproduction by increased iNOS activities in brain of AI rats can also cause nitrosylation in a variety of proteins such as PKC, 50 which appeared to inhibit nNOS phosphorylation further.
Procyanidins are oligomers and polymers of polyhydroxy flavan-3-ol monomeric subunits [(À)-epicatechin and/or (þ)-catechin]. Many potential health benefits of procyanidins have been reported, and most of them are often claimed to be based on their antioxidant properties. 15, 51 The metabolites of procyanidins can cross the blood-brain barrier and be taken up and detected in brain 52 and thus exert neuroprotective properties. For example, previous experiments have demonstrated that procyanidins had inhibiting effects on lipid peroxidation, 14, 53 protein oxidation, and accumulation of age-related oxidative DNA damage 54 in the brain. The basic mechanisms of antioxidant activity of procyanidins are free radical scavenging activity, chelation of transition metals, and inhibition of prooxidative enzymes. 15 Recently, procyanidins were also reported to change the production of NO by regulating NOS isoforms activities in vivo or in vitro. 15, 18, 31, 55 In this study, both doses of LSPC significantly decreased iNOS activities and consequently resulted in a decrease of tNOS activities and NO levels in the hippocampus and cerebral cortex of AI animals. It had been reported that the protein-binding action of procyanidins is one of the possible mechanisms to explain the inhibitory effect of procyanidins on NOS activity. 15, 31 The transcriptional control of the iNOS gene is of prime importance for the regulation of its enzymatic activity, and procyanidins inhibited iNOS gene and consequent protein expression in AI animals directly 55 and indirectly (through their antiinflammatory property 15 ). LSPC supplementation thereby slashed the activity of iNOS and consequently decreased NO overproduction through these mechanisms. However, LSPC supplementation did not lead to marked alterations for hippocampal and cortical nNOS activity in AI animals, whereas AI animals revealed a trend to increase nNOS gene and protein expression in hippocampus with LSPC supplementation. As a result, animals in LSPC supplementation groups should have a decline in nNOS activity per unit protein in hippocampus. Moreover, although LSPC supplementation did not have a marked effect on the percentages of hippocampal nNOS activity change in the presence of protein kinase inhibitors in AI animals, these compounds 40 XU ET AL.
considerably altered these percentages in these animals in the presence of phosphatase inhibitor. These results implied that LSPC supplementation was able to change the hippocampal nNOS phosphorylation state and reduce the sustained catalytic activities per unit of enzyme in AI animals. The declined catalytic activities per unit of nNOS would lead to scaling down the levels of hippocampal nNOS activity, but the deficits were made up by increasing enzyme expression. In brief, although animals in both LSPC supplementation groups exhibited significant lower hippocampal nNOS activity compared with AU animals, LSPC supplementation regulated hippocampal nNOS phosphorylation effectively and also showed a trend of increased hippocampal nNOS expression. LSPC may increase nNOS sensitivity to Ca 2þ /calmodulin and subsequently increase hippocampal NO/sGC/cGMP signal transduction in AI animals and facilitate the induction of LTP. In addition, LSPC also provided cognitive benefits in AI animals by protecting against oxidative stress 19 induced by excessive NO. In conclusion, our present results showed that aged animals suffered elevated iNOS activities and decreased nNOS activities in hippocampus and cerebral cortex, but these changes were more pronounced in the brain of AI rats, especially in the hippocampus. These results suggested that the changes in hippocampal iNOS and nNOS activity might involve the progression of cognitive deficits in AI animals. A decreased hippocampal nNOS phosphorylation state as well as increased iNOS activity induced overproduction of NO, which was implicated in cognitive deterioration. Declining hippocampal NO/sGC/cGMP signal transduction by sustained nNOS dephosphorylation state may also be a potential mechanism for age-related cognitive impairment. LSPC supplementation not only decreased hippocampal iNOS activities and enzyme expression but also regulated hippocampal nNOS phosphorylation effectively in AI animals, which led to the inhibition of age-related NO overproduction and increase of hippocampal NO/sGC/cGMP signal transduction in these animals. These changes in hippocampal NO system may involve, at least partly, in the ameliorative effects of LSPC on learning and memory dysfunction in AI animals. 19 
